Literature DB >> 16574918

Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project.

Peter L Kolominsky-Rabas1, Peter U Heuschmann, Daniela Marschall, Martin Emmert, Nikoline Baltzer, Bernhard Neundörfer, Oliver Schöffski, Karl J Krobot.   

Abstract

BACKGROUND AND
PURPOSE: The number of stroke patients and the healthcare costs of strokes are expected to rise. The objective of this study was to determine the direct costs of first ischemic stroke and to estimate the expected increase in costs in Germany.
METHODS: An incidence-based, bottom-up, direct-cost-of-ischemic-stroke study from the third-party payer's perspective was performed, incorporating 10-year survival data and 5-year resource use data from the Erlangen Stroke Registry. Discounted lifetime year 2004 costs per case were obtained and applied to the expected age and sex evolution of the German resident population in the period 2006 to 2025.
RESULTS: The overall cost per first-year survivor of first-ever ischemic stroke was estimated to be 18,517 euros (EUR). Rehabilitation accounted for 37% of this cost, whereas in subsequent years outpatient care was the major cost driver. Discounted lifetime cost per case was 43,129 EUR overall and was higher in men (45,549 EUR) than in women (41,304 EUR). National projections for the period 2006 to 2025 showed 1.5 million and 1.9 million new cases of ischemic stroke in men and women, respectively, at a present value of 51.5 and 57.1 billion EUR, respectively.
CONCLUSIONS: The number of stroke patients and the healthcare costs of strokes in Germany will rise continuously until the year 2025. Therefore, stroke prevention and reduction of stroke-related disability should be made priorities in health planning policies.

Entities:  

Mesh:

Year:  2006        PMID: 16574918     DOI: 10.1161/01.STR.0000217450.21310.90

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  69 in total

1.  Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease.

Authors:  Klaus Bonaventura; Alexander W Leber; Christian Sohns; Mattias Roser; Leif-Hendrik Boldt; Franz X Kleber; Wilhelm Haverkamp; Marc Dorenkamp
Journal:  Clin Res Cardiol       Date:  2012-02-21       Impact factor: 5.460

2.  Imaging of acute ischemic stroke.

Authors:  Carlos Leiva-Salinas; Max Wintermark
Journal:  Neuroimaging Clin N Am       Date:  2010-11       Impact factor: 2.264

3.  Cost-Effectiveness Analysis of the DiagnOSAS Screening Tool Compared With Polysomnography Diagnosis in Dutch Primary Care.

Authors:  Floris A J Geessinck; Rick G Pleijhuis; Rob J Mentink; Job van der Palen; Hendrik Koffijberg
Journal:  J Clin Sleep Med       Date:  2018-06-15       Impact factor: 4.062

4.  Hospital costs of ischemic stroke and TIA in the Netherlands.

Authors:  Leander R Buisman; Siok Swan Tan; Paul J Nederkoorn; Peter J Koudstaal; William K Redekop
Journal:  Neurology       Date:  2015-05-01       Impact factor: 9.910

Review 5.  A review of the cost of cardiovascular disease.

Authors:  Jean-Eric Tarride; Morgan Lim; Marie DesMeules; Wei Luo; Natasha Burke; Daria O'Reilly; James Bowen; Ron Goeree
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

6.  Increasing comorbidity and health services utilization in older adults with prior stroke.

Authors:  Andrea Gruneir; Lauren E Griffith; Kathryn Fisher; Dilzayn Panjwani; Sima Gandhi; Li Sheng; Chris Patterson; Amiram Gafni; Jenny Ploeg; Maureen Markle-Reid
Journal:  Neurology       Date:  2016-10-19       Impact factor: 9.910

7.  Economic burden of stroke: a systematic review on post-stroke care.

Authors:  S Rajsic; H Gothe; H H Borba; G Sroczynski; J Vujicic; T Toell; Uwe Siebert
Journal:  Eur J Health Econ       Date:  2018-06-16

Review 8.  Acute stroke magnetic resonance imaging: current status and future perspective.

Authors:  Stephan P Kloska; Max Wintermark; Tobias Engelhorn; Jochen B Fiebach
Journal:  Neuroradiology       Date:  2009-12-05       Impact factor: 2.804

9.  The 5-year direct medical cost of neonatal and childhood stroke in a population-based cohort.

Authors:  M A Gardner; N K Hills; S Sidney; S C Johnston; H J Fullerton
Journal:  Neurology       Date:  2010-01-06       Impact factor: 9.910

10.  Intracarotid administration of human bone marrow mononuclear cells in rat photothrombotic ischemia.

Authors:  Jens Minnerup; Florian H Seeger; Katharina Kuhnert; Kai Diederich; Matthias Schilling; Stefanie Dimmeler; Wolf-Rüdiger Schäbitz
Journal:  Exp Transl Stroke Med       Date:  2010-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.